Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease
Open Access
- 1 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (2) , 199-205
Abstract
Background. Noninvasive, sensitive, and specific tools for early identification of chronic inflammatory bowel disease (IBD) are needed for clinical praKeywords
This publication has 42 references indexed in Scilit:
- New serological markers in inflammatory bowel disease are associated with complicated disease behaviourGut, 2007
- Analysis of Serum Antibodies in Patients Suspected of Having Inflammatory Bowel DiseaseClinical and Vaccine Immunology, 2006
- Serologic Markers in Inflammatory Bowel DiseaseClinical Chemistry, 2006
- New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel DiseaseImmunopharmacology and Immunotoxicology, 2006
- Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2006
- Anti- Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel diseaseGut, 2005
- Anti- Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn’s diseaseGut, 2004
- Antineutrophil Cytoplasmic Antibodies, Anti-Saccharomyces cerevisiae Antibodies, and Specific IgE to Food Allergens in Children with Inflammatory Bowel DiseasesClinical Immunology, 2002
- Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy childrenActa Paediatrica, 2002
- Molecular Cloning of aBacteroides caccaeTonB-Linked Outer Membrane Protein Identified by an Inflammatory Bowel Disease Marker AntibodyInfection and Immunity, 2001